마이크로톰 시장 보고서 : 제품별, 기술별, 최종사용자별, 지역별(2026-2034년)

The global microtome market size reached USD 182.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 260.4 Million by 2034, exhibiting a growth rate (CAGR) of 4.00% during 2026-2034. The growing prevalence of oncological disorders, rising adoption in the field of neuroscience, and increasing improvement in the healthcare infrastructure represent some of the key factors driving the market.

Microtome is a specialized machine that is designed for precision tissue sectioning purposes and cutting thin and uniform slices of biological samples obtained from plants and animals. It comprises specialized blades made from metal, glass, or diamond, which are chosen as per the different specimens and sample thicknesses. It also consists of a block holder, knife clamps, block adjustments, a thickness gauge, and an operating handle. It is commercially sold in numerous forms, such as hand-held, rotational, vibrating, sledge, cryostat, and ultramicrotome. Microtome is also available as base-sledge microtome, which is useful for cutting extremely hard blocks and large sections, and the knife is sledge shaped, which requires less honing. It provides numerous cutting modes, such as single, interval, multi, and continuous high throughput serial sectioning. It is extensively used in histology to prepare tissue sections for examination under a microscope and diagnose diseases or investigate cellular structure and functions.

MICROTOME MARKET TRENDS:

At present, the increasing demand for microtomes due to the rising prevalence of oncological disorders around the world represents one of the significant factors influencing the market positively. Besides this, the growing utilization of semi and fully-automatic microtomes to extract minor sections of tissues and detect the presence of tumor cells in the body is offering a favorable market outlook. In addition, the increasing employment of microtomes in botany to make thin sections of plant tissues for examination of the structure and function of different plant parts, such as stomata, root cells, and stem cells, is propelling the growth of the market. Apart from this, the rising adoption of microtomes in the field of neuroscience to prepare thin sections of brain and spinal cord tissue samples for detailed examination of the cellular and molecular structure of the nervous system and understanding the mechanisms of various neurological disorders is contributing to the growth of the market. Additionally, the increasing preference for using microtomes in various scientific laboratories, as they can be adjusted to produce tissue sections of varying thickness, allowing researchers and pathologists to tailor the sectioning procedure according to their needs, is supporting the growth of the market. Moreover, the rising improvement in the healthcare infrastructure to provide quality treatment and diagnosis to patients is bolstering the growth of the market.

KEY MARKET SEGMENTATION:

PRODUCT INSIGHTS:

• Microtome Devices
  • Rotary Microtome
  • Vibrating Microtome
  • Others
• Accessories

TECHNOLOGY INSIGHTS:

• Fully Automated
• Semi-Automated
• Manual

END USER INSIGHTS:

• Hospital Laboratories
• Clinical Laboratories

REGIONAL INSIGHTS:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for microtome. Some of the factors driving the North America microtome market included the growing advancements in the medical sector, rising occurrence of chronic diseases, increasing prevalence of cancer among the masses, etc.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global microtome market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered AGD Biomedical Pvt Ltd., Amos Scientific Pty Ltd, Boeckeler Instruments Inc, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, MEDITE GmbH, MICROS Produktions- und HandelsgesmbH, Sakura Finetek Europe B.V., SLEE medical GmbH, SM Scientific Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How has the global microtome market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global microtome market?
• What is the impact of each driver, restraint, and opportunity on the global microtome market?
• What are the key regional markets?
• Which countries represent the most attractive microtome market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the microtome market?
• What is the breakup of the market based on the technology?
• Which is the most attractive technology in the microtome market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the microtome market?
• What is the competitive structure of the global microtome market?
• Who are the key players/companies in the global microtome market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Microtome Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Microtome Devices
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Rotary Microtome
    • 6.1.2.2 Vibrating Microtome
    • 6.1.2.3 Others
  • 6.1.3 Market Forecast
• 6.2 Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Fully Automated
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Semi-Automated
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Manual
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospital Laboratories
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinical Laboratories
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 AGD Biomedical Pvt Ltd
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Amos Scientific Pty Ltd
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Boeckeler Instruments Inc
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Leica Biosystems Nussloch GmbH
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 LLS ROWIAK LaserLabSolutions GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 MEDITE GmbH
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 MICROS Produktions- und HandelsgesmbH
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Sakura Finetek Europe B.V.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 SLEE medical GmbH
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 SM Scientific Instruments Pvt. Ltd.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Thermo Fisher Scientific Inc.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis